Search research articles
Contact Us
Filters
Showing results (221-230 of 247) with videos related to
Page
of 25
Sort By:
Nature Communications
|
March 7, 2025
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype
Phillip S Gross, Violeta Durán-Laforet, Lana T Ho, et al.
Cancer Chemotherapy and Pharmacology
|
June 2, 2007
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB
Vincent A Pollack, Enrique Alvarez, Kam Fai Tse, et al.
The Journal of Infectious Diseases
|
October 4, 2017
PD-L1 Overexpression During Endotoxin Tolerance Impairs the Adaptive Immune Response in Septic Patients via HIF1α
José Avendaño-Ortiz, Charbel Maroun-Eid, Alejandro Martín-Quirós, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption
Enrique Alvarez, Michael Westmore, Rachelle J Sells Galvin, et al.
Neurology
|
November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorder
Eric C Klawiter, Riley Bove, Liene Elsone, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study
Riley Bove, Liene Elsone, Enrique Alvarez, et al.
Journal of Neuroimmunology
|
September 4, 2023
SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients
Tyler L Borko, Ryan Baxter, Berenice Cabrera-Martinez, et al.
Neurology
|
November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications
Carson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
The New England Journal of Medicine
|
August 24, 2022
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis
Lawrence Steinman, Edward Fox, Hans-Peter Hartung, et al.
Neurology. Clinical Practice
|
January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 247) with videos related to
Sort By:
Page
of 25
Nature Communications
|
March 7, 2025
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype
Phillip S Gross, Violeta Durán-Laforet, Lana T Ho, et al.
Cancer Chemotherapy and Pharmacology
|
June 2, 2007
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB
Vincent A Pollack, Enrique Alvarez, Kam Fai Tse, et al.
The Journal of Infectious Diseases
|
October 4, 2017
PD-L1 Overexpression During Endotoxin Tolerance Impairs the Adaptive Immune Response in Septic Patients via HIF1α
José Avendaño-Ortiz, Charbel Maroun-Eid, Alejandro Martín-Quirós, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption
Enrique Alvarez, Michael Westmore, Rachelle J Sells Galvin, et al.
Neurology
|
November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorder
Eric C Klawiter, Riley Bove, Liene Elsone, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study
Riley Bove, Liene Elsone, Enrique Alvarez, et al.
Journal of Neuroimmunology
|
September 4, 2023
SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients
Tyler L Borko, Ryan Baxter, Berenice Cabrera-Martinez, et al.
Neurology
|
November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications
Carson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
The New England Journal of Medicine
|
August 24, 2022
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis
Lawrence Steinman, Edward Fox, Hans-Peter Hartung, et al.
Neurology. Clinical Practice
|
January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.
Page
of 25